Status:
COMPLETED
Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma
Lead Sponsor:
Ayhman Al Afif
Collaborating Sponsors:
Nova Scotia Health Authority
Conditions:
Head and Neck Neoplasms
Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18-100 years
Phase:
PHASE2
Brief Summary
Objectives: Transoral Laser Microsurgery (TLM) is widely used in for treating T1/T2 glottic cancers. Hyaluronic acid (HA) is a safe and commonly-used injectable in vocal cord augmentation. We report o...
Eligibility Criteria
Inclusion
- Males and females
- 18 years of age or older with a biopsy-proven T1a, T1b or T2 glottic SCC
- Lesion amenable to CO2 TLM resection.
Exclusion
- Previous radiotherapy to the head and neck.
- Palpable, or radiographic, pathological lymphadenopathy.
- Allergy, or sensitivity, to HA or components of the injectable.
- Neurological disorder affecting phonation, such as multiple sclerosis or stroke.
Key Trial Info
Start Date :
August 13 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 13 2018
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04525066
Start Date
August 13 2013
End Date
August 13 2018
Last Update
August 25 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.